Remifentanil differs from other synthetic opioids in that it undergoes metabolism by which mechanism, making it ideal for continuous infusion in anesthesia?

Explanation

## Remifentanil Pharmacokinetics: Unique Metabolism **Key Point:** Remifentanil is metabolized by rapid plasma and tissue esterase hydrolysis, resulting in a context-sensitive half-time of only 3–4 minutes, independent of infusion duration. This makes it uniquely suited for continuous intraoperative infusion with rapid offset. ### Comparison of Synthetic Opioid Metabolism | Opioid | Metabolism | Elimination Half-life | Context-Sensitive Half-time | Clinical Use | |--------|-----------|----------------------|-----------------------------|--------------| | **Remifentanil** | Plasma/tissue esterase | 10–20 min | **3–4 min (constant)** | Continuous infusion; rapid offset | | **Fentanyl** | Hepatic CYP3A4 | 3–7 hours | 40–50 min (increases with duration) | Bolus or short infusion | | **Sufentanil** | Hepatic metabolism | 2–3 hours | 40 min (increases with duration) | Bolus dosing | | **Morphine** | Hepatic conjugation | 2–4 hours | 60+ min | Bolus; slower offset | **High-Yield:** Context-sensitive half-time (CSHT) is the time for plasma concentration to fall by 50% after stopping an infusion. Remifentanil's CSHT remains constant (~3–4 min) regardless of infusion duration, whereas other opioids show prolonged CSHT with longer infusions due to peripheral redistribution and accumulation. **Clinical Pearl:** Remifentanil's rapid esterase metabolism means it is NOT affected by hepatic or renal dysfunction, making it safe in patients with organ impairment. However, its rapid offset requires careful planning for postoperative analgesia (transition to longer-acting opioid before infusion ends). **Mnemonic:** **ESTER** — **E**sterase metabolism makes **S**hort **T**ime for **E**limination, **R**apid recovery.